PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Going against the flow: Halting atherosclerosis by targeting micro RNA

2013-12-18
(Press-News.org) Contact information: Quinn Eastman
qeastma@emory.edu
404-727-7829
Emory Health Sciences
Going against the flow: Halting atherosclerosis by targeting micro RNA Researchers at Emory and Georgia Tech have developed a potential treatment for atherosclerosis that targets a master controller of the process.

The results are scheduled for publication Dec. 18 in the journal Nature Communications.

In a twist, the master controller comes from a source that scientists had thought was leftover garbage. It is a micro RNA molecule, which comes from an unused template that remains after punching out ribosomes –– workhorse protein factories found in all cells.

The treatment works by stopping the inflammatory effects of disturbed blood flow on cells that line blood vessels. In animal models of atherosclerosis, a drug that blocks the micro RNA can stop arteries from becoming blocked, despite the ongoing stress of high-fat diet. The micro RNA appears to function similarly in human cells.

"We've known that aerobic exercise provides protection against atherosclerosis, partly by improving patterns of blood flow. Now we're achieving some insight into how," says senior author Hanjoong Jo, PhD. "Healthy flow tunes down the production of bad actors like this micro RNA. Targeting it could form the basis for a therapeutic approach that could be translated with relative ease compared to other drugs."

Jo is John and Jan Portman professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. The co-first authors of the paper are postdoctoral fellows Dong Ju Son, PhD and Sandeep Kumar, PhD.

In atherosclerosis, arterial walls thicken because of a gradual build-up of white blood cells, lipids and cholesterol. The process can lead to plaque formation, and eventually to heart attacks and strokes.

Atherosclerosis occurs preferentially in branched or curved regions of arteries, because of the patterns of blood flow imposed by the shape of blood vessels. Constant, regular flow of blood appears to promote healthy blood vessels, while erratic or turbulent flow can lead to disease.

Jo and his colleagues have developed an animal model where it is possible to drive the development of atherosclerosis quickly and selectively, by partially restricting blood flow in a mouse's carotid artery. To accelerate the process, the mice also have a deficiency in ApoE, important for removing lipids and cholesterol from the blood, and are fed a high-fat diet. The model allows researchers to compare molecules that are activated in endothelial cells, which line blood vessels, on the disturbed side versus the undisturbed side in the same animal.

Son and Kumar focused on micro RNAs, short snippets of RNA that can inhibit the activity of many genes at once. Micro RNAs were recently discovered to be able to travel from cell to cell, and thus could orchestrate processes such as atherosclerosis. Out of all the micro RNAs the researchers examined, one in particular, called miR-712, was the micro RNA most strongly induced by disturbed blood flow in the atherosclerosis model system.

In response to disturbed or unhealthy blood flow, endothelial cells produce miR-712, the researchers found. miR-712 in turn inhibits a gene called TIMP3, which under healthy flow conditions restrains inflammation in endothelial cells.

The researchers were surprised to find that miR-712 comes from leftovers remaining from a long RNA that is used to form ribosomes. Ribosomes are ubiquitous and perform the basic housekeeping function of protein assembly.

"This is one of the most abundant streams of RNA that cells produce, and it turns out to be the source for a molecule that controls atherosclerosis," Jo says. "Why did nature do it that way? I don't think we know yet."

By using a technology called "locked nucleic acids," Jo and his colleagues tested the effects of blocking miR-712 in the body. When given to mice in the rapid atherosclerosis model, the anti-miR-712 drug inhibited the development of arterial blockages. Without the drug, plaques blocked an average of 80 percent of the disturbed carotid artery, but the drug cut that in half. The drug worked similarly in another model of atherosclerosis where animals develop disease more slowly.

Locked nucleic acids that target an unrelated disease (hepatitis C) are being tested in clinical trials, and so far appear to be effective. A micro RNA similar to miR-712 appears to have the same inflammatory control function in human endothelial cells; it's called miR-205.

Jo says his team is devising ways using nanotechnologies to deliver anti-miR-712 drugs to the heart or to endothelial cells specifically to achieve efficient therapeutic effect with minimum side-effects.

"It is notable that in our experiments, the anti-miR-712 drug was delivered systemically, but still made its way to the right place and had a strong effect," Jo says. "This is a good sign for future translational studies."

### The research was supported by the National Heart Lung and Blood Institute (HL095070, HL70531), the Center for Translational Cardiovascular Nanomedicine (HHSN268201000043C), the American Heart Association and the South Korean Ministry of Science, Technology and Education.


ELSE PRESS RELEASES FROM THIS DATE:

New guidelines for management of high blood pressure released

2013-12-18
New guidelines for management of high blood pressure released A new guideline for the management of high blood pressure, developed by an expert panel and containing nine recommendations and a treatment algorithm (flow chart) to help doctors treat patients ...

Scientists find a groovy way to influence specialization of stem cells

2013-12-18
Scientists find a groovy way to influence specialization of stem cells Researchers at Queen Mary University of London have shown for the first time that the specialised role stem cells go on to perform is controlled by primary cilia –tiny hair-like ...

Mass shootings will not substantially decrease with more armed guards or background checks

2013-12-18
Mass shootings will not substantially decrease with more armed guards or background checks Criminology scholars debunk 11 myths about mass murder in a special issue of Homicide Studies Los Angeles, CA (December 5, 2013) With the one-year anniversary of the ...

Study led by NUS scientists provides new insights into cause of human neurodegenerative disease

2013-12-18
Study led by NUS scientists provides new insights into cause of human neurodegenerative disease Research team identified Neurexin2 as a novel target for potential therapy of neurodegeneration in Spinal Muscular Atrophy patients Singapore, 18 December ...

Debate continues on impact of artificial sweeteners

2013-12-18
Debate continues on impact of artificial sweeteners New research from the University of Adelaide has added to the debate about how our bodies respond to artificial sweeteners and whether they are good, bad or have no effect on us. In a study published ...

Dogs recognize familiar faces from images

2013-12-18
Dogs recognize familiar faces from images Humans have specific brain mechanisms involved in face processing, which focuses attention to faces and recognizes the identity of faces remarkably quickly and accurately. So far the specialized skill for recognizing ...

Low-cost countries are not the best conservation investment

2013-12-18
Low-cost countries are not the best conservation investment Published in PLOS ONE and titled "Cheap and Nasty? The Potential Perils of Using Management Costs to Identify Global Conservation Priorities", the research is the first to investigate links between conservation ...

How hypergravity impacts electric arcs

2013-12-18
How hypergravity impacts electric arcs A new study on electric discharge behaviour under intense gravitational forces shows that its dynamic changes as gravity increases Arc discharges are common in everyday conditions like welding or in lightning storms. But ...

Polymer coatings based on molecular structures

2013-12-18
Polymer coatings based on molecular structures KIT researchers developing a novel gel for biological and medical applications This news release is available in German. A novel method developed by researchers from Karlsruhe Institute of Technology (KIT) ...

Computer-controlled table could direct radiotherapy to tumours while sparing vital organs

2013-12-18
Computer-controlled table could direct radiotherapy to tumours while sparing vital organs Swivelling patients around on a computer-controlled, rotating table could deliver high doses of radiotherapy to tumours more quickly than current methods, while sparing ...

LAST 30 PRESS RELEASES:

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

[Press-News.org] Going against the flow: Halting atherosclerosis by targeting micro RNA